Wockhardt gets US FDA nod for anti-hypertensive drug (PharmaBiz)
Wockhardt Ltd has received approval from the US FDA for marketing Lisinopril in the US market. Wockhardt Ltd has received approval from the US FDA for marketing Lisinopril in the US market.

New products boosts Ranbaxy's net by 79% in Q1 (PharmaBiz)
Ranbaxy Laboratories has achieved better performance during the first quarter ended March 2007. The company's net profit has taken a quantum jump of 79 per cent and reached at Rs 128.70 crore from Rs 71.80 crore in the corresponding period of last year.